Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
41.33
-2.11 (-4.86%)
Aug 3, 2026, 3:04 PM CST
SHE:002422 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 18,382 | 18,513 | 21,812 | 21,454 | 19,038 | 17,277 |
Revenue Growth | -8.01% | -15.13% | 1.67% | 12.69% | 10.19% | 4.94% |
Gross Profit Gross Profit Growth | 8,539 | 8,746 | 11,200 | 11,163 | 9,954 | 9,284 |
Operating Income Operating Income Growth | 1,648 | 2,105 | 4,044 | 3,407 | 2,260 | 1,484 |
Net Income Net Income Growth | 1,571 | 1,702 | 2,936 | 2,456 | 1,705 | 1,103 |
Earnings Per Share EPS Growth | 0.99 | 1.07 | 1.86 | 1.59 | 1.15 | 0.78 |
EPS Growth | -36.86% | -42.47% | 16.98% | 38.26% | 47.44% | 34.48% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Twinings Branch Twinings Branch Growth | 4,616 |
Botai Branch Botai Branch Growth | 2,058 |
Other Business Segments Other Business Segments Growth | 12,147 |
Intersegment Offset Intersegment Offset Growth | -308.54 |
Total Total Growth | 18,513 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 8,268 | 8,124 | 6,451 | 6,946 | 5,177 | 3,279 |
Total Debt Total Debt Growth | 4,816 | 4,208 | 4,207 | 7,139 | 11,285 | 11,916 |
Net Cash (Debt) Net Cash Growth | 3,452 | 3,916 | 2,243 | -193.52 | -6,108 | -8,637 |
Net Cash Growth | 100.24% | 74.58% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 2.18 | 2.46 | 1.42 | -0.13 | -4.12 | -6.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,442 | 2,642 | 4,493 | 5,337 | 3,127 | 2,847 |
Capital Expenditures CapEx Growth | -1,622 | -1,622 | -1,678 | -1,769 | -896.7 | -990.56 |
Free Cash Flow Free Cash Flow Growth | 820.42 | 1,020 | 2,815 | 3,568 | 2,230 | 1,857 |
Free Cash Flow Growth | -61.11% | -63.78% | -21.11% | 59.98% | 20.13% | 87.82% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 46.45% | 47.24% | 51.35% | 52.03% | 52.29% | 53.74% |
Operating Margin | 8.97% | 11.37% | 18.54% | 15.88% | 11.87% | 8.59% |
Pretax Margin | 11.27% | 12.98% | 19.65% | 16.69% | 10.86% | 6.82% |
Profit Margin | 8.55% | 9.19% | 13.46% | 11.45% | 8.96% | 6.38% |
FCF Margin | 4.46% | 5.51% | 12.90% | 16.63% | 11.71% | 10.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.594 | 0.594 | 0.763 | 0.800 | 0.616 | 0.426 |
Dividend Per Share Growth | -22.15% | -22.15% | -4.63% | 29.87% | 44.60% | 33.63% |
Dividend Yield | 1.37% | 2.05% | 2.63% | 2.93% | 2.52% | 2.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 43.87 | 27.43 | 16.17 | 17.44 | 21.89 | 24.15 |
Forward PE | 30.36 | 23.59 | 15.69 | 21.36 | 21.81 | 18.84 |
P/FCF Ratio | 84.21 | 45.79 | 16.87 | 12.00 | 16.74 | 14.34 |
PS Ratio | 3.76 | 2.52 | 2.18 | 2.00 | 1.96 | 1.54 |